An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals
Samantha C. Shapiro, MD
Samantha C. Shapiro, MD, is a clinician educator who practices telerheumatology and writes for both medical and lay audiences. She earned her medical degree from Baylor College of Medicine, Houston, and was inducted into Alpha Omega Alpha Honor Medical Society. In 2018, she completed her internal medicine residency and rheumatology fellowship training at Johns Hopkins University, Baltimore. Fresh out of training, she founded the Division of Rheumatology at Dell Medical School at The University of Texas at Austin, where she remains an affiliate faculty member. In September 2021, she left her full-time academic position to pursue her main passions: clinical education, patient education, advocacy and international travel. She works with various telehealth services to improve access to rheumatologic care. She educates patients and physicians as a medical writer and enjoys writing for both lay and medical audiences. She is an active member of the ACR, volunteering her time to the ACR’s Insurance Subcommittee.
Urine biomarkers have the potential to change how lupus nephritis is managed, serving as a noninvasive means of early detection, assessing treatment response and more.
This year, Dr. Sam Shapiro underwent total hip arthroplasty. Her journey from being an athlete to suffering from arthritis and chronic joint pain was difficult. Here is her story, complete with post-op insights.
In part 2 of Dr. Sam Shapiro’s journey, learn how she connected with the rheumatology community to change her career and found a better way to embrace her passions for clinical rheumatology, education and helping patients.
Dr. Samantha Shapiro recounts her enthusiastic and ambitious early career in rheumatology—a path that culminated in burnout and a brave choice with new opportunities.
Compassion, clear communication, empathy and more—Samantha C. Shapiro, MD, provides practical advice on how to connect with your patients during appointments.
Sendaydiego et al. asked: Do some DMARDs pose a greater cancer risk than others for patients with RA? Here are insights from the study and its clinical implications.
Patients with RA not only suffer from functional limitations, but also face increased healthcare costs, primarily due to prescription drug use, says Dr. Yinan Huang.